Corporate Member News

DrFirst Responds to Trump Administration's Position on Opioid Crisis

DrFirst, the market leader in e-prescribing and medication management solutions, has issued its response to the President's Commission on Combating Drug Addiction and the Opioid Crisis, which recently issued a report with recommendations. With the added gravity of the Centers for Disease Control and Prevention (CDC) announcing that life expectancy has fallen for the second year in a row as opioid-related deaths have surged, the company offers its support in dealing with the national crisis.